Role of CHK2 in cancer development

被引：30
作者：
Perona, Rosario [1 ,2 ]
Moncho-Amor, Veronica [1 ,2 ]
Machado-Pinilla, Rosario [1 ,2 ]
Belda-Iniesta, Cristobal [3 ]
Sanchez Perez, Isabel [1 ,2 ]
机构：
[1] Univ Autonoma Madrid, CSIC, Inst Invest Biomed, ES-28029 Madrid, Spain
[2] UAM, CSIC, CIBERER, Translat Oncol Unit, Valencia, Spain
[3] Univ Autonoma Madrid, Univ Hosp La Paz, Div Med Oncol, CSIC,Translat Oncol Unit, ES-28029 Madrid, Spain
来源：
CLINICAL & TRANSLATIONAL ONCOLOGY | 2008年 / 10卷 / 09期
关键词：
CHK2; ATM; ATR; DNA damage; checkpoints; chemotherapy;
D O I：
10.1007/s12094-008-0248-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DNA repair pathways enable tumour cells to survive DNA damage induced by external agents such as therapeutic treatments. Signalling cascades involved in these pathways comprise the DNA-dependent protein kinase (DNA-PK), Ataxia-telangiectasia mutated (ATM), ATM and Rad3 related (ATR) and checkpoint kinases I and 2 (Chk1/Chk2), among others. ATM and ATR phosphorylate, respectively, Chk2 and Chk1, leading to activation of checkpoints. Chk2 acts as a signal distributor, dispersing checkpoint signal to downstream targets such as p53, Cdc25A, Cdc25C, BRCA1 and E2F1. A role of Chk2 as a candidate tumour suppressor has been suggested based on both mouse genetics and somatic tumour studies. We will discuss here the possible role of this kinase in human carcinogenesis and the possibility to use it as a target to increment DNA damage in cancer cells in response to DNA-damaging therapies.
引用
收藏
页码：538 / 542
页数：5
相关论文
共 50 条
[41]   Condensin recruitment to chromatin is inhibited by Chk2 kinase in response to DNA damage [J].
Zhang, Tao ;
Si-Hoe, San Ling ;
Hudson, Damien F. ;
Surana, Uttam .
CELL CYCLE, 2016, 15 (24) :3454-3470
[42]   CHK2 sets the stage for CK1 in oocyte quality control [J].
Kehrloesser, Sebastian ;
Tuppi, Marcel ;
Doetsch, Volker .
CELL DEATH AND DIFFERENTIATION, 2018, 25 (06) :1007-1009
[43]   Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase [J].
H Fujimoto ;
N Onishi ;
N Kato ;
M Takekawa ;
X Z Xu ;
A Kosugi ;
T Kondo ;
M Imamura ;
I Oishi ;
A Yoda ;
Y Minami .
Cell Death & Differentiation, 2006, 13 :1170-1180
[44]   p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2 [J].
Urist, M ;
Tanaka, T ;
Poyurovsky, MV ;
Prives, C .
GENES & DEVELOPMENT, 2004, 18 (24) :3041-3054
[45]   Chk2 down-regulation by promoter hypermethylation in human bulk gliomas [J].
Wang, Hongwei ;
Wang, Shuai ;
Shen, Liqin ;
Chen, Yuanyuan ;
Zhang, Xiaotian ;
Zhou, Jundong ;
Wang, Zhi ;
Hu, Chengyi ;
Yue, Wu ;
Wang, Huibo .
LIFE SCIENCES, 2010, 86 (5-6) :185-191
[46]   Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer [J].
Alkema, N. G. ;
Tomar, T. ;
van der Zee, A. G. J. ;
Everts, M. ;
Meersma, G. J. ;
Hollema, H. ;
de Jong, S. ;
van Vugt, M. A. T. M. ;
Wisman, G. B. A. .
GYNECOLOGIC ONCOLOGY, 2014, 133 (03) :591-598
[47]   Chk2 and p53 Are Haploinsufficient with Dependent and Independent Functions to Eliminate Cells after Telomere Loss [J].
Kurzhals, Rebeccah L. ;
Titen, Simon W. A. ;
Xie, Heng B. ;
Golic, Kent G. .
PLOS GENETICS, 2011, 7 (06)
[48]   DNA damage-induced S phase arrest in human breast cancer depends on Chk1, but G2 arrest can occur independently of Chk1, Chk2 or MAPKAPK2 [J].
Zhang, Wen-Hui ;
Poh, Alisa ;
Fanous, Andrew A. ;
Eastman, Alan .
CELL CYCLE, 2008, 7 (11) :1668-1677
[49]   Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin [J].
Shi, Yandong ;
Felley-Bosco, Emanuela ;
Marti, Thomas M. ;
Orlowski, Katrin ;
Pruschy, Martin ;
Stahel, Rolf A. .
BMC CANCER, 2012, 12
[50]   CHK2 Inhibition Provides a Strategy to Suppress Hematologic Toxicity from PARP Inhibitors [J].
Xu, Zhen ;
Vandenberg, Cassandra J. ;
Lieschke, Elizabeth ;
Di Rago, Ladina ;
Scott, Clare L. ;
Majewski, Ian J. .
MOLECULAR CANCER RESEARCH, 2021, 19 (08) :1350-1360
12345